Yersinia pestis Activates Both IL-1β and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague

被引:26
|
作者
Sivaraman, Vijay [1 ,2 ]
Pechous, Roger D. [1 ]
Stasulli, Nikolas M. [1 ]
Miao, Edward A. [1 ]
Goldman, William E. [1 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA
[2] N Carolina Cent Univ, Dept Biol, Durham, NC USA
基金
美国国家卫生研究院;
关键词
CASPASE-1; ACTIVATION; IMMUNE-RESPONSES; SECRETION; INNATE; VIRULENCE; RECOGNITION; MACROPHAGES; PATHOLOGY; PROTEIN; INJURY;
D O I
10.1371/journal.ppat.1004688
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumonic plague is the most rapid and lethal form of Yersinia pestis infection. Increasing evidence suggests that Y. pestis employs multiple levels of innate immune evasion and/or suppression to produce an early "pre-inflammatory" phase of pulmonary infection, after which the disease is highly inflammatory in the lung and 100% fatal. In this study, we show that IL-1 beta/IL-18 cytokine activation occurs early after bacteria enter the lung, and this activation eventually contributes to pulmonary inflammation and pathology during the later stages of infection. However, the inflammatory effects of IL-1 beta/IL-1-receptor ligation are not observed during this first stage of pneumonic plague. We show that Y. pestis also activates the induction of IL-1 receptor antagonist (IL-1RA), and this activation likely contributes to the ability of Y. pestis to establish the initial pre-inflammatory phase of disease.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [21] Crystal structure of an IL-1 receptor antagonist peptide complexed with IL-1 receptor type I
    Brandhuber, BJ
    Dripps, DJ
    Edwards, CK
    Vigers, GPA
    FASEB JOURNAL, 2000, 14 (08): : A1394 - A1394
  • [22] Polymorphisms for interleukin-1β (IL-1β)-511 promoter, IL-1β exon 5, and IL-1 receptor antagonist:: Nonassociation with endometriosis
    Hsieh, YY
    Chang, CC
    Tsai, FJ
    Wu, JY
    Shi, YR
    Tsai, HD
    Tsai, CH
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (09) : 506 - 511
  • [23] Immunohistochemical staining of IL-1α, IL-1β and IL-1 receptor antagonist in murine co-cultures of Sertoli/germ cells
    Lunenfeld, E
    Huleihel, M
    Zeyse, D
    Beck, M
    Prinsloo, I
    Potashnik, G
    Mazor, M
    HUMAN REPRODUCTION, 2000, 15 : 85 - 85
  • [24] Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II
    Ruggiero, P
    Bossu, P
    Macchia, G
    DelGrosso, E
    Sabbatini, V
    Bertini, R
    Colagrande, A
    Bizzarri, C
    Maurizi, G
    DiCioccio, V
    DAndrea, G
    DiGiulio, A
    Frigerio, F
    Grifantini, R
    Grandi, G
    Tagliabue, A
    Boraschi, D
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3881 - 3887
  • [25] MODULATION OF THE IL-1 CYTOKINE NETWORK IN KERATINOCYTES BY INTRACELLULAR IL-1-ALPHA AND IL-1 RECEPTOR ANTAGONIST
    PHILLIPS, WG
    FELDMANN, M
    BREATHNACH, SM
    BRENNAN, FM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 101 (01): : 177 - 182
  • [26] A tissue specific IL-1 receptor antagonist homolog front the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities
    Barton, JL
    Herbst, R
    Bosisio, D
    Higgins, L
    Nicklin, MJH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3299 - 3308
  • [27] INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST BINDS TO THE 80-KDA IL-1 RECEPTOR BUT DOES NOT INITIATE IL-1 SIGNAL TRANSDUCTION
    DRIPPS, DJ
    BRANDHUBER, BJ
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (16) : 10331 - 10336
  • [28] Interleukin-1α (IL-1α), IL-1β, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-β1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors
    Ilyin, SE
    Gonzalez-Gomez, I
    Gilles, FH
    Plata-Salaman, CR
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (02) : 125 - 137
  • [29] HUMAN AND BOVINE IL-1 RECEPTORS DISCRIMINATE BETWEEN HOMOLOGOUS AND HETEROLOGOUS IL-1 BUT NOT THE HUMAN IL-1 RECEPTOR ANTAGONIST (IL-1RA)
    LEDERER, J
    CZUPRYNSKI, C
    FASEB JOURNAL, 1991, 5 (05): : A1341 - A1341
  • [30] Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist
    Vamvakopoulos, J
    Green, C
    Metcalfe, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (10) : 2988 - 2996